In February 2022, Arcensus has been accredited by the American Association for Laboratory Accreditation (A2LA) in accordance with the internationally recognized Standard ISO 15189:2022 for Bioinformatic Services. The accreditation was renewed in November 2023, with an additional expansion of its scope.<\/p>\n\n\n\n
The A2LA\u2019s accreditation recognizes that Arcensus follows international quality standards and has the required competencies to carry out advanced genetic testing based on Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES) as well as the clinical reporting from raw sequence data.<\/p>\n\n\n\n
Arcensus holds the ISO 15189:2022 accredited by A2LA. This is a testament to our commitment to international quality standards and our dedication to continuously maintaining the highest standards in bioinformatics services.<\/p>\n\n\n\n
American Association for Laboratory Accreditation (A2LA) is among the largest accreditation bodies in the world and the only independent, 501(c)3, non-profit, internationally recognized accreditation body in the United States that offers a full range of comprehensive conformity assessment accreditation services. The laboratory is currently undergoing the certification process for ISO 27001 and CAP accreditation, scheduled for completion in the first and second quarters of 2024.<\/p>\n\n\n\n
A2LA was established in 1978 as a public service membership society; it is dedicated to the formal recognition of competent testing and calibration laboratories (including medical laboratories), biobanking facilities, inspection bodies, product certification bodies and proficiency testing providers and reference material producers. A2LA has over 4,000 actively accredited certificates representing all 50 US states and more than 50 countries.<\/p>\n\n\n\n